(Inclusive of all Taxes)
Get Free delivery (₹99)
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
సంఘటన :
ఎర్లోటినిబ్-150ఎంజి
తయారీదారు/మార్కెటర్ :
సిప్లా లిమిటెడ్
వినియోగ రకం :
నోటి ద్వారా
రిటర్న్ పాలసీ :
3 రోజుల్లో తిరిగి ఇవ్వవచ్చు
వీటి తర్వాత లేదా వీటిపై గడువు ముగుస్తుంది :
Jan-27
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Erlonat 150 mg Tablet:
Omeprazole can make Erlonat 150 mg Tablet less effective by reducing its absorption in the body. This can lead to low treatment outcomes.
How to manage the interaction:
Taking Omeprazole and Erlonat 150 mg Tablet together is not recommended as it can result in an interaction; it should be taken only if a doctor has advised it. Do not stop using any medications without talking to a doctor.
Omeprazole can make Erlonat 150 mg Tablet less effective by reducing its absorption in the body. This can lead to low treatment outcomes.
How to manage the interaction:
Taking Omeprazole and Erlonat 150 mg Tablet together is not recommended as it can result in an interaction; it should be taken only if a doctor has advised it. Do not stop using any medications without talking to a doctor.
Critical
How does the drug interact with Erlonat 150 mg Tablet:
When used in combination with Erlonat 150 mg Tablet, Rabeprazole may prevent the absorption of Erlonat 150 mg Tablet into the circulation, which might make Erlonat 150 mg Tablet less effective in treating cancer.
How to manage the interaction:
Taking Rabeprazole with Erlonat 150 mg Tablet is not recommended as it can result in an interaction, it should be taken only if a doctor has advised it. Do not stop using any medications without consulting a doctor.
When used in combination with Erlonat 150 mg Tablet, Rabeprazole may prevent the absorption of Erlonat 150 mg Tablet into the circulation, which might make Erlonat 150 mg Tablet less effective in treating cancer.
How to manage the interaction:
Taking Rabeprazole with Erlonat 150 mg Tablet is not recommended as it can result in an interaction, it should be taken only if a doctor has advised it. Do not stop using any medications without consulting a doctor.
Severe
How does the drug interact with Erlonat 150 mg Tablet:
The combination of Erlonat 150 mg Tablet with lansoprazole is commonly not advised. Erlonat 150 mg Tablet may be less effective at treating your cancer as lansoprazole may interfere with Erlonat 150 mg Tablet's absorption into the bloodstream.
How to manage the interaction:
Although taking Lansoprazole and Erlonat 150 mg Tablet together can possibly result in an interaction, it can be taken if your doctor has prescribed it. Without consulting a doctor, never stop taking any drugs.
The combination of Erlonat 150 mg Tablet with lansoprazole is commonly not advised. Erlonat 150 mg Tablet may be less effective at treating your cancer as lansoprazole may interfere with Erlonat 150 mg Tablet's absorption into the bloodstream.
How to manage the interaction:
Although taking Lansoprazole and Erlonat 150 mg Tablet together can possibly result in an interaction, it can be taken if your doctor has prescribed it. Without consulting a doctor, never stop taking any drugs.
How does the drug interact with Erlonat 150 mg Tablet:
When Erlonat 150 mg Tablet is taken with primidone, it reduces the blood levels of Erlonat 150 mg Tablet. This can lead to low treatment outcomes.
How to manage the interaction:
Taking Erlonat 150 mg Tablet with Primidone together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not stop using any medications without talking to a doctor.
When Erlonat 150 mg Tablet is taken with primidone, it reduces the blood levels of Erlonat 150 mg Tablet. This can lead to low treatment outcomes.
How to manage the interaction:
Taking Erlonat 150 mg Tablet with Primidone together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not stop using any medications without talking to a doctor.
ErlotinibRanitidine bismuth citrate
Severe
How does the drug interact with Erlonat 150 mg Tablet:
Coadministration of Ranitidine bismuth citrate with Erlonat 150 mg Tablet can interfere with the absorption of Erlonat 150 mg Tablet and reduce its effectiveness.
How to manage the interaction:
Taking Ranitidine bismuth citrate with Erlonat 150 mg Tablet together can result in an interaction, but it can be taken if your doctor has advised it. When taken together, your doctor can recommend other options that won't cause any problems. Do not stop using any medications without talking to a doctor.
Coadministration of Ranitidine bismuth citrate with Erlonat 150 mg Tablet can interfere with the absorption of Erlonat 150 mg Tablet and reduce its effectiveness.
How to manage the interaction:
Taking Ranitidine bismuth citrate with Erlonat 150 mg Tablet together can result in an interaction, but it can be taken if your doctor has advised it. When taken together, your doctor can recommend other options that won't cause any problems. Do not stop using any medications without talking to a doctor.
ErlotinibRifapentine
Severe
How does the drug interact with Erlonat 150 mg Tablet:
When Erlonat 150 mg Tablet is taken with rifapentine, it reduces the blood levels of Erlonat 150 mg Tablet.
How to manage the interaction:
Although there is a possible interaction between Erlonat 150 mg Tablet and Rifapentine, you can take these medicines together if advised by a doctor. Do not discontinue any medications without first consulting a doctor.
When Erlonat 150 mg Tablet is taken with rifapentine, it reduces the blood levels of Erlonat 150 mg Tablet.
How to manage the interaction:
Although there is a possible interaction between Erlonat 150 mg Tablet and Rifapentine, you can take these medicines together if advised by a doctor. Do not discontinue any medications without first consulting a doctor.
Severe
How does the drug interact with Erlonat 150 mg Tablet:
Taking Erlonat 150 mg Tablet with Teriflunomide can increase the risk or severity of liver damage.
How to manage the interaction:
Taking Erlonat 150 mg Tablet with Teriflunomide together is generally avoided as it can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Taking Erlonat 150 mg Tablet with Teriflunomide can increase the risk or severity of liver damage.
How to manage the interaction:
Taking Erlonat 150 mg Tablet with Teriflunomide together is generally avoided as it can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Erlonat 150 mg Tablet:
Erlonat 150 mg Tablet's effects and blood levels could both be enhanced by ketoconazole.
How to manage the interaction:
Although taking Ketoconazole and Erlonat 150 mg Tablet together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, if you develop severe or ongoing diarrhea, nausea, vomiting, lack of appetite, skin rash, shortness of breath, cough, or fever, consult a doctor.
Erlonat 150 mg Tablet's effects and blood levels could both be enhanced by ketoconazole.
How to manage the interaction:
Although taking Ketoconazole and Erlonat 150 mg Tablet together can possibly result in an interaction, it can be taken if your doctor has prescribed it. However, if you develop severe or ongoing diarrhea, nausea, vomiting, lack of appetite, skin rash, shortness of breath, cough, or fever, consult a doctor.
ErlotinibLomitapide
Severe
How does the drug interact with Erlonat 150 mg Tablet:
Taking Erlonat 150 mg Tablet and Lomitapide can increase the risk or severity of liver damage.
How to manage the interaction:
Taking Erlonat 150 mg Tablet and Lomitapide is generally avoided as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Taking Erlonat 150 mg Tablet and Lomitapide can increase the risk or severity of liver damage.
How to manage the interaction:
Taking Erlonat 150 mg Tablet and Lomitapide is generally avoided as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
ErlotinibMitotane
Severe
How does the drug interact with Erlonat 150 mg Tablet:
When Erlonat 150 mg Tablet is taken with mitotane, it reduces the blood levels of Erlonat 150 mg Tablet.This can lead to low treatment outcomes.
How to manage the interaction:
Co-administration of Erlonat 150 mg Tablet with Mitotane can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not stop using any medications without a doctor's advice.
When Erlonat 150 mg Tablet is taken with mitotane, it reduces the blood levels of Erlonat 150 mg Tablet.This can lead to low treatment outcomes.
How to manage the interaction:
Co-administration of Erlonat 150 mg Tablet with Mitotane can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not stop using any medications without a doctor's advice.
Drug-Food Interactions
ERLOTINIB-150MGGrapefruit and Grapefruit Juice
Moderate
Drug-Food Interactions
Login/Sign Up
ERLOTINIB-150MGGrapefruit and Grapefruit Juice
Moderate
Common Foods to Avoid:
Grapefruit Juice
How to manage the interaction:
Grapefruit juice can increase the absorption of Erlonat 150 mg Tablet which may lead to higher blood levels of Erlonat 150 mg Tablet and possibly increased side effects. Avoid or limit the consumption of Grapefruit juice or Grapefruit while taking Erlonat 150 mg Tablet as it can lead to increased risk or severity of side effects. However, if you notice any Burning, tingling, numbness or pain in the hands, arms, feet, or legs, cough or hoarseness, or severe diarrhea, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Grapefruit Juice
How to manage the interaction:
Grapefruit juice can increase the absorption of Erlonat 150 mg Tablet which may lead to higher blood levels of Erlonat 150 mg Tablet and possibly increased side effects. Avoid or limit the consumption of Grapefruit juice or Grapefruit while taking Erlonat 150 mg Tablet as it can lead to increased risk or severity of side effects. However, if you notice any Burning, tingling, numbness or pain in the hands, arms, feet, or legs, cough or hoarseness, or severe diarrhea, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
మద్యం
అసురక్షితం
మీరు Erlonat 150 mg టాబ్లెట్ 30's తో మద్యం సేవించకుండా ఉండాలని సిఫార్సు చేయబడింది ఎందుకంటే ఇది మైకము, మగత లేదా ఏకాగ్రతలో ఇబ్బంది వంటి దుష్ప్రభావాల ప్రమాదాన్ని పెంచుతుంది.
గర్భం
అసురక్షితం
Erlonat 150 mg టాబ్లెట్ 30's గర్భంలో ఉపయోగించడానికి పరిమితం చేయబడింది. ఈ మందుతో చికిత్స ప్రారంభించే ముందు ఒక మహిళకు ప్రతికూల గర్భ పరీక్ష ఉండాలి. ఈ మందు తీసుకుంటున్నప్పుడు లేదా Erlonat 150 mg టాబ్లెట్ 30's యొక్క చివరి మోతాదు తీసుకున్న తర్వాత కనీసం 6 నెలల వరకు గర్భం రాకుండా ఉండటానికి ప్రభావవంతమైన జనన నియంత్రణ పద్ధతులను ఉపయోగించడం మంచిది.
తల్లిపాలు ఇవ్వడం
అసురక్షితం
Erlonat 150 mg టాబ్లెట్ 30's తల్లిపాలు ఇచ్చే తల్లులు తీసుకోకూడదు ఎందుకంటే ఇది తల్లిపాలలోకి వెళుతుంది మరియు శిశువుకు ప్రమాదాన్ని కలిగిస్తుంది.
డ్రైవింగ్
జాగ్రత్త
Erlonat 150 mg టాబ్లెట్ 30's మీ డ్రైవింగ్ సామర్థ్యాన్ని ప్రభావితం చేస్తుందో లేదో తెలియదు. మీరు శారీరకంగా స్థిరంగా మరియు మానసికంగా దృష్టి కేంద్రీకరించినప్పుడు మాత్రమే డ్రైవ్ చేయండి. ఈ మందు తీసుకున్న తర్వాత మీరు మగత అనుభవిస్తే, మీరు డ్రైవ్ చేయకూడదు లేదా ఏదైనా యంత్రాలు లేదా వాహనాలను నడపకూడదు.
కాలేయం
జాగ్రత్త
కాలేయ వ్యాధితో బాధపడుతున్న రోగులలో Erlonat 150 mg టాబ్లెట్ 30's జాగ్రత్తగా తీసుకోవాలి. రోగి యొక్క వైద్య పరిస్థితి ప్రకారం వైద్యుడు మోతాదును సర్దుబాటు చేయవచ్చు.
కిడ్నీ
జాగ్రత్త
వారి వైద్యుడు సూచించినట్లుగా కిడ్నీ వ్యాధితో బాధపడుతున్న రోగులు Erlonat 150 mg టాబ్లెట్ 30's తీసుకోవడం సురక్షితం. రోగి యొక్క వైద్య పరిస్థితి ప్రకారం వైద్యుడు మోతాదును సర్దుబాటు చేయవచ్చు.
పిల్లలు
అసురక్షితం
18 సంవత్సరాల కంటే తక్కువ వయస్సు ఉన్న పిల్లలకు Erlonat 150 mg టాబ్లెట్ 30's సిఫార్సు చేయబడలేదు ఎందుకంటే భద్రత మరియు ప్రభావం స్థాపించబడలేదు.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
